Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Bank of America
BAC
HK Stock MarketDetailed Quotes
02197 CLOVER BIO-B
- 0.193
- -0.004-2.03%
Market Closed May 15 16:08 CST
250.33MMarket Cap-0.26P/E (TTM)
0.197High0.193Low204.00KVolume0.197Open0.197Pre Close39.75KTurnover0.02%Turnover RatioLossP/E (Static)1.30BShares0.58052wk High-0.14P/B250.33MFloat Cap0.18552wk Low--Dividend TTM1.30BShs Float14.800Historical High--Dividend LFY2.03%Amplitude0.185Historical Low0.194Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
CLOVER BIO-B News
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2025
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2025
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENTCLOVER ANNOUNCES U.S. IND CLEARANCE ANDINITIATION OF REVACCINATION CLINICAL STUDY FORRSV VACCINE CANDIDATE SCB-1019
CLOVER BIO-B: INSIDE INFORMATION
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2025
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2025
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2024
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2024
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2024
CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024
CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE CLINICAL DATA FOR RSV VACCINE CANDIDATE SCB-1019 COMPARED HEAD-TO-HEAD VERSUS GSK'S AREXVY
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024
CLOVER BIO-B: Letter to Registered Shareholders - New Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2024
CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024
CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2024
CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2024
CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2024
CLOVER BIO-B: FIFTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting